Literature DB >> 18424738

Alternatively activated myeloid cells limit pathogenicity associated with African trypanosomiasis through the IL-10 inducible gene selenoprotein P.

Tom Bosschaerts1, Martin Guilliams, Wim Noel, Michel Hérin, Raymond F Burk, Kristina E Hill, Lea Brys, Geert Raes, Gholamreza Hassanzadeh Ghassabeh, Patrick De Baetselier, Alain Beschin.   

Abstract

Uncontrolled inflammation is a major cause of tissue injury/pathogenicity often resulting in death of a host infected with African trypanosomes. Thus, comparing the immune response in hosts that develop different degrees of disease severity represents a promising approach to discover processes contributing to trypanosomiasis control. It is known that limitation of pathogenicity requires a transition in the course of infection, from an IFN-gamma-dependent response resulting in the development of classically activated myeloid cells (M1), to a counterbalancing IL-10-dependent response associated with alternatively activated myeloid cells (M2). Herein, mechanisms and downstream effectors by which M2 contribute to lower the pathogenicity and the associated susceptibility to African trypanosomiasis have been explored. Gene expression analysis in IL-10 knockout and wild-type mice, that are susceptible and relatively resistant to Trypanosoma congolense infection, respectively, revealed a number of IL-10-inducible genes expressed by M2, including Sepp1 coding for selenoprotein P. Functional analyses confirm that selenoprotein P contributes to limit disease severity through anti-oxidant activity. Indeed, Sepp1 knockout mice, but not Sepp1(Delta)(240-361) mice retaining the anti-oxidant motif but lacking the selenium transporter domain of selenoprotein P, exhibited increased tissue injury that associated with increased production of reactive oxygen species and increased apoptosis in the liver immune cells, reduced parasite clearance capacity of myeloid cells, and decreased survival. These data validate M2-associated molecules as functioning in reducing the impact of parasite infection on the host.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424738     DOI: 10.4049/jimmunol.180.9.6168

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

Review 1.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.

Authors:  Zhi Huang; Aaron H Rose; Peter R Hoffmann
Journal:  Antioxid Redox Signal       Date:  2012-01-09       Impact factor: 8.401

2.  Dietary selenium affects host selenoproteome expression by influencing the gut microbiota.

Authors:  Marina V Kasaikina; Marina A Kravtsova; Byung Cheon Lee; Javier Seravalli; Daniel A Peterson; Jens Walter; Ryan Legge; Andrew K Benson; Dolph L Hatfield; Vadim N Gladyshev
Journal:  FASEB J       Date:  2011-04-14       Impact factor: 5.191

Review 3.  Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease.

Authors:  Sarah P Short; Jennifer M Pilat; Christopher S Williams
Journal:  Free Radic Biol Med       Date:  2018-05-17       Impact factor: 7.376

Review 4.  Understanding selenoprotein function and regulation through the use of rodent models.

Authors:  Marina V Kasaikina; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Biochim Biophys Acta       Date:  2012-03-13

Review 5.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

6.  Sepp1(UF) forms are N-terminal selenoprotein P truncations that have peroxidase activity when coupled with thioredoxin reductase-1.

Authors:  Suguru Kurokawa; Sofi Eriksson; Kristie L Rose; Sen Wu; Amy K Motley; Salisha Hill; Virginia P Winfrey; W Hayes McDonald; Mario R Capecchi; John F Atkins; Elias S J Arnér; Kristina E Hill; Raymond F Burk
Journal:  Free Radic Biol Med       Date:  2014-01-14       Impact factor: 7.376

7.  Role for parasite genetic diversity in differential host responses to Trypanosoma brucei infection.

Authors:  Liam J Morrison; Sarah McLellan; Lindsay Sweeney; Chi N Chan; Annette MacLeod; Andy Tait; C Michael R Turner
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

8.  Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling.

Authors:  Tom Bosschaerts; Martin Guilliams; Benoît Stijlemans; Yannick Morias; Daniel Engel; Frank Tacke; Michel Hérin; Patrick De Baetselier; Alain Beschin
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

Review 9.  The human selenoproteome: recent insights into functions and regulation.

Authors:  M A Reeves; P R Hoffmann
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

10.  A major genetic locus in Trypanosoma brucei is a determinant of host pathology.

Authors:  Liam J Morrison; Andy Tait; Sarah McLellan; Lindsay Sweeney; C Michael R Turner; Annette MacLeod
Journal:  PLoS Negl Trop Dis       Date:  2009-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.